Pay in 4 interest-free payments of $6.11 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Mechanism of action G-actin sequestration driving actin polymerization, ILK-PI3K-Akt cell survival signaling, VEGF-mediated angiogenesis, MMP-driven ECM remodeling, NF-B anti-inflammatory modulation Typical research dosage Beginner protocol mg / Woche Advanced protocol 2.5-5 mg twice weekly, subcutaneously Note: The dosages listed correspond to typical ranges from published research literature
Gently swirl the vial to mix the contents without agitation
This formulation combines Cartalax, TB-500, and BPC-157 into a single research blend, providing researchers with a valuable tool for examining coordinated peptide signaling, pathway convergence, and complementary mechanisms involved in tissue organization and extracellular matrix regulation within controlled laboratory environments
If any side effect persists or worsens, contact your prescriber promptly
US$ 28.12
US$ 21.83
US$ 27.32
US$ 22.69
